Senior Stability Scientist
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Senior Stability Scientist
Exciting opportunity to take part in the development of Symphogen’s antibody medicines.
https://uhc.dk/wp-content/uploads/2022/10/VideoannonceQ-2.mp4
As Senior Stability Scientist at Symphogen, you will be a member of the Stability and Formulation Team, Drug Product Development Department in CMC Biologics, that are responsible for the early and late-stage development of the antibody portfolio.
You will report directly to Lise Smith Sørensen, Team Manager, Stability and Formulation.
You will lead and participate in development projects being responsible for setting the stability strategy and execution to ensure the development progress of antibody candidates.
Your main tasks are:
Your qualifications include experience with the development of biopharmaceuticals, knowledge and understanding of ICH, stability testing of lyophilized and/or device-biologics combination products, and the associated regulatory documentation.
You have a relevant education as cand.pharm., cand.scient., cand.polyt. or equivalent.
You are a person who is self-driven, highly motivated, with humor, and a team player. Open and accommodating approach, both towards colleagues as well as to various tasks and challenges. Demonstrates critical thinking with attention to detail and a pragmatic and problem-solving mindset. You are fluent in English and possess great communication skills, written and verbal (English).
Symphogen offers a challenging and versatile job in an innovative, flexible, focused, and committed biotech environment. The environment is marked by strong cross-functional teamwork, with room for diversity, individual performance and development, and most importantly, passionate and fun colleagues! As an employee in Symphogen, you will be part of a highly engaged and inspiring organization, and you will have the opportunity to influence job content and set your footprint on improving the lives of cancer patients.
Traveling: Limited travel both in the EU and outside the EU, including visits to Servier Group.
Domicile: In commuting distance from the Symphogen office in Ballerup.
For more details about the job or the company, please contact CEO Jørn Duhn on M: +45 21 75 19 25, Director Life Science Gert Vium Andersen on M: +45 42 95 08 83. All applications must be in English and are treated confidentially.
Exciting opportunity to take part in the development of Symphogen’s antibody medicines.
https://uhc.dk/wp-content/uploads/2022/10/VideoannonceQ-2.mp4
As Senior Stability Scientist at Symphogen, you will be a member of the Stability and Formulation Team, Drug Product Development Department in CMC Biologics, that are responsible for the early and late-stage development of the antibody portfolio.
You will report directly to Lise Smith Sørensen, Team Manager, Stability and Formulation.
You will lead and participate in development projects being responsible for setting the stability strategy and execution to ensure the development progress of antibody candidates.
Your main tasks are:
- Responsible for internal and external stability studies, incl. technical products
- Collaborate with colleagues from the CMC Biologics group and be a member of cross-functional project teams
- CMO follow-up, authoring, and review of regulatory documentation
Your qualifications include experience with the development of biopharmaceuticals, knowledge and understanding of ICH, stability testing of lyophilized and/or device-biologics combination products, and the associated regulatory documentation.
You have a relevant education as cand.pharm., cand.scient., cand.polyt. or equivalent.
You are a person who is self-driven, highly motivated, with humor, and a team player. Open and accommodating approach, both towards colleagues as well as to various tasks and challenges. Demonstrates critical thinking with attention to detail and a pragmatic and problem-solving mindset. You are fluent in English and possess great communication skills, written and verbal (English).
Symphogen offers a challenging and versatile job in an innovative, flexible, focused, and committed biotech environment. The environment is marked by strong cross-functional teamwork, with room for diversity, individual performance and development, and most importantly, passionate and fun colleagues! As an employee in Symphogen, you will be part of a highly engaged and inspiring organization, and you will have the opportunity to influence job content and set your footprint on improving the lives of cancer patients.
Traveling: Limited travel both in the EU and outside the EU, including visits to Servier Group.
Domicile: In commuting distance from the Symphogen office in Ballerup.
For more details about the job or the company, please contact CEO Jørn Duhn on M: +45 21 75 19 25, Director Life Science Gert Vium Andersen on M: +45 42 95 08 83. All applications must be in English and are treated confidentially.
Information og data
Denne ledige stilling har jobtypen "Forsker", og befinder sig i kategorien "Sundhed og forskning".
Jobbet er oprettet på vores service den 13.10.2022, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forsker
Statistik over udbudte jobs som forskere
Herunder ser du udviklingen i udbudte forsker over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forskere.
Se flere statistikker her:
Statistik over udbudte forskere over tid
Dato | Alle jobs som forskere |
---|---|
7. november 2024 | 404 |
6. november 2024 | 405 |
5. november 2024 | 391 |
4. november 2024 | 387 |
3. november 2024 | 398 |
2. november 2024 | 402 |
1. november 2024 | 425 |
31. oktober 2024 | 439 |
30. oktober 2024 | 433 |
29. oktober 2024 | 433 |
28. oktober 2024 | 438 |
27. oktober 2024 | 473 |
26. oktober 2024 | 477 |
25. oktober 2024 | 399 |
24. oktober 2024 | 446 |
23. oktober 2024 | 468 |
22. oktober 2024 | 473 |
21. oktober 2024 | 440 |
20. oktober 2024 | 472 |
19. oktober 2024 | 464 |
18. oktober 2024 | 416 |
17. oktober 2024 | 423 |
16. oktober 2024 | 402 |
15. oktober 2024 | 411 |
14. oktober 2024 | 370 |
13. oktober 2024 | 398 |
12. oktober 2024 | 383 |
11. oktober 2024 | 361 |
10. oktober 2024 | 401 |
9. oktober 2024 | 386 |
8. oktober 2024 | 389 |